However, though not significant, there was an observable trend in increased tumor multiplicity in mice co-treated developing organism. Strain-dependent differences in the The carcinogenic effects of in utero exposure to 3-methylKi-ras mutational spectrum may be associated with their cholanthrene (MC) have been demonstrated in the differential susceptibility to lung tumor initiation. tumor-resistant C57BL/6 (B6) and DBA (D2) strains of mice. In this study, we determined the effects of in utero exposure to MC in BALB/c mice, a strain which demonIntroduction strates greater susceptibility to lung tumor induction, and compared our findings with those previously found in
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The developing fetus is highly sensitive to the effects of in [D2⍥B6D2F 1 ]F 2 mice. In addition, we assessed the molecuutero exposure to environmental toxicants, such as those found lar pathogenesis of the chemically induced tumors and in cigarette smoke and in other forms of air pollution (1-3). examined the effects of the putative lung tumor promoter
Oxidative metabolism of these agents by both the mother and butylated hydroxytoluene (BHT) in BALB/c mice. BALB/ fetus causes DNA damage in tissues of transplacentally exposed c mice were treated on day 17 of gestation with 5, 15 or fetuses, as well as multiple developmental impairments (4,5). 45 mg/kg MC and 6 weeks after birth with BHT for 6 Prenatal exposure to similar compounds also increases the risk consecutive weeks. Mice were killed at 6 months of age.
of adult and childhood cancers (6,7). Polycyclic aromatic Ki-ras, p16 Ink4a and p19 ARF gene loci were amplified from hydrocarbons (PAHs), present in tobacco smoke, charbroiled paraffin-embedded lung tumor tissue and screened for the foods and air pollution, are potent carcinogens (8). PAHs presence of point mutations via allele-specific oligonucleoreadily cross the placental membrane to induce fetal tide hybridization and single strand conformation polycytochrome P4501A1 (CYP1A1), which converts these commorphism (SSCP) analyses. Ki-ras point mutations were pounds into DNA-damaging molecules (9,10). A strong associfound in 56% (20/36) of BALB/c lung tumors, with 33% ation is seen between induction of CYP1A1 and levels of (2/6) of the hyperplasias, 58% (10/19) of the adenomas and PAH-DNA adducts in human cord blood and placental tissues 73% (8/11) of the carcinomas exhibiting point mutations (11, 12) and rodent lung and liver tissue (13). This appears to at this gene locus. Similar incidences of Ki-ras mutations correlate with the incidence of transplacentally induced lung were previously found following transplacental exposure tumors (2,3,14,15).
of [D2⍥B6D2F 1 ]F 2 mice to MC and treatment of adult
Tumor formation is a multistep process in which the loss A/J mice with urethane. Interestingly, a strain-dependent of growth control is an early step, with cell cycle regulatory difference was observed in the mutational spectrum. Sixtygenes playing important roles in this process. Mutational two and 38% of the lung lesions in BALB/c mice exhibited activation of the proto-oncogene ras occurs in~30% of all G→C and G→T transversions, respectively, in contrast human tumors (16). Alterations in the Ki-ras isoform are to the 13 and 84% incidences previously observed in particularly prevalent in lung neoplasms (17,18). Mutational [D2⍥B6D2F 1 ]F 2 mice. SSCP analysis of the tumor supinactivation of tumor suppressor genes, such as p16 Ink4a and pressor gene p16 Ink4a showed a 6% incidence of point p53, is also frequently observed (19-21). These genes behave mutations, consistent with that found in [D2⍥B6D2F 1 ]F 2 primarily as negative regulators of cellular proliferation, hence, mice. No mutations were found in exon 1β of the p19 ARF when mutated the cell loses a critical 'brake' on cell growth gene of either strain. BHT, a lung tumor promoter in adult which can ultimately result in the formation of tumors (22 can result in unregulated cellular proliferation. Likewise, The role of proto-oncogenes and tumor suppressor genes in exon 2 5Ј primer 5Ј-TACAGGAAACAAGTAATTGATGGAG-AA-3Ј
tumorigenesis in the adult model has been well studied, 3Ј primer 5Ј-ATAATGGTGAATATCTTCAAATGATTThowever, little is known about the molecular alterations in these cell regulatory genes in transplacentally induced neoplasia.
p16 Ink4a exon 1α 5Ј primer 5Ј-GGTCACACGACTGGGCGATT-3Ј
The induction of tumors following in utero exposure to 3-3Ј primer 5Ј-GAATCGGGGTACGACCGAAA-3Ј methylcholanthrene (MC) has previously been demonstrated exon 2 5Ј primer 5Ј-GTGATGATGATGGGCAACGT-3Ј 3Ј primer 5Ј-GGGCGTGCTTGAGCTGAAGC-3Ј
in the relatively tumor-resistant C57BL/6 (B6) and DBA/2 p19 ARF exon 1β 5Ј primer 5Ј-GCATGGGTCGCAGGGTTCTTGG-3Ј
(D2) strains of mice (14,24), but not in the more sensitive 3Ј primer 5Ј-CCTGGTCCAGGATTCCGGTGC-3Ј
BALB/c mice. Differences in lung tumor susceptibility between these strains has been ascribed to several genes (25) . A Amplification conditions are listed in Materials and methods.
polymorphism in the second intron of Ki-ras plays a major role in lung tumor susceptibility, as determined using carcinogenesis
Animals and treatment protocol protocols in adult mice (25, 26) . The Ki-ras allele found in
Paraffin-embedded [D2ϫB6D2F 1 ]F 2 lung tissue was generated as described in a previous study (24 (Table I ). The samples were overlaid ication (32); BHT preferentially induces apoptosis in normal with 100 µl of mineral oil to prevent evaporation and cross-contamination of cells (33) .
the samples. The PCR cycle parameters for exons 1 and 2 of the Ki-ras gene consisted of an initial 2 min denaturation step at 94°C, followed by 40 cycles
The serious risks associated with in utero exposure to of 1 min at 94°C, 2 min at 50°C and 2 min at 74°C, with a final extension environmental carcinogens necessitate the need for further step of 74°C for 7 min. For exons 1α and 2 of p16 Ink4a , an initial denaturation study in this area. The present study is part of our ongoing step of 94°C for 2 min was followed by 40 successive cycles of 1 min at efforts to assess environmental/genetic interactions relating to 94°C, 2 min at 58°C and 2 min at 72°C, with a final extension step of 72°C
in utero exposure to PAH. We demonstrate herein strain for 7 min. To amplify exon 1β of p19 ARF , an initial denaturation step of 94°C for 2 min was followed by 40 successive cycles of 1 min at 94°C, 2 min at differences in the effects of MC on offspring from different 67°C and 2 min at 72°C, with a final extension step of 72°C for 7 min. Each strains of mice, on the mutational spectrum of MC-induced reaction included deparaffination procedure controls, which lacked tumor tumors and on the effects of BHT on tumor yield.
tissue but were mock extracted, and amplification negative controls, which lacked template DNA and served as negative buffer controls for the PCR amplification reactions. All samples were amplified in an Ericomp DeltaCycler Ki-ras codons 12, 13 and 61 (Clontech, Palo Alto, CA). The filters were prehybridized in oligonucleotide buffer at 37°C for 1.5 h. Following the addition of an oligomer 5Ј-end-labeled with 32 P (5ϫ10 6 c.p.m./ml), the injection of either corn oil (control group) or with 5, 15 or 45 mg/kg MC Each band was placed in 100 µl of nuclease-free water and heated to 80°C dissolved in corn oil. Six weeks after birth, mice were treated with weekly for 15 min. Thirty microliter aliquots were amplified as described above i.p. injections of either corn oil or 200 mg/kg BHT dissolved in corn oil for except that the number of cycles was reduced to 30. DNA was purified from 6 consecutive weeks. At 6 months of age, the mice were killed by CO 2 low melting point agarose gels and cloned using the TA Cloning Kit asphyxiation and lung tumors were fixed in 10% formalin and embedded in (Invitrogen, San Diego, CA). Briefly, gel-purified products were ligated into paraffin. Tumor multiplicity is reported as means Ϯ SD. pCRII cloning vectors and used to transform Escherichia coli. Plasmid DNA b On day17 of gestation, [D2ϫB6D2F 1 ]F 2 mice were treated with a single was isolated from transformed colonies using Qiagen columns (Qiagen, i.p. injection of either olive oil (control group) or 10 or 30 mg/kg MC Chatsworth, CA) and sequenced using the ABI Prism sequencing kit. Ki-ras dissolved in olive oil. At 1 year of age, the mice were killed by cervical was sequenced directly from the initial PCR products. DNA sequence analysis dislocation and lung tumors were fixed in 10% formalin and embedded in was done using DNASIS software (Hitachi Software Engineering America, paraffin. Tumor multiplicity is reported as means Ϯ SD. Tumor incidence San Bruno, CA). To control for false positives, tumors were considered data were previously reported by Wessner et al. (24) . positive for mutations only when identical results were determined in a second independent experiment. All samples were sequenced in the forward and reverse directions to eliminate the possibility of polymerase-induced errors treated with vehicle or with the lowest dose of MC Ϯ BHT during sequencing.
Materials and methods

II
(5 mg/kg) developed no macroscopically visible lung tumors;
Statistical analysis mice treated with higher doses had tumor incidences ranging Statistical analysis of the incidence and mutational spectra in lung tumors of from 20 to 100% (Table II) . Dose-dependent increases in [D2ϫB6D2F 1 ]F 2 mice was previously reported (24, 37) . Briefly, χ 2 and tumor incidence and multiplicity were statistically significant Cochran-Mantel-Haenszel tests were performed to determine whether tumor stage and mutation type were independent of each other and whether there (P Ͻ 0.05, incidence; P Ͻ 0.001, multiplicity) in both was an ordered association. In the present study, a χ 2 test was used to assess BHT-treated and untreated groups. BHT co-treatment the significance of the difference in lung tumor incidence between the groups increased tumor multiplicity in the 15 and 45 mg/kg groups of BALB/c mice defined by their MC dose and BHT status. Logistical over that observed in mice treated with MC alone, howregression was then used to assess the joint effect of BHT and dose level and ever, the differences were only of borderline significance their interaction on tumor incidence. Rank analysis of covariance was used to assess the joint effects of BHT and dose level on tumor multiplicity. Models (0.1 Ͻ P Ͻ 0.15 at both doses). Despite the differences in were run with and without an interaction between BHT and dose and with susceptibility to lung tumorigenesis observed in adult mice dose considered categorically and continuously. Separate models were run to (25) , tumor incidences in the BALB/c mice were similar to assess the effect of BHT at each dose level. Fisher's exact test was used to those found in [D2ϫB6D2F 1 ]F 2 mice (Table II) . This may be assess the association between tumor stage and mutation type and between BHT and mutation type. related to the time course of the experimental protocols.
[D2ϫB6D2F 1 ]F 2 mice were killed following a 1 year bioassay, while BALB/c mice were killed following a 6 month bioassay.
Results
It is possible that the incidence of tumors in BALB/c mice would have been significantly greater than that found in In the present study, the role of genetic and environmental interactions on the initiation and pathogenesis of transplacen-[D2ϫB6D2F 1 ]F 2 mice if the bioassay was carried out for a longer period of time. In addition, the resistant mice exhibit tally induced lung tumors was investigated. BALB/c mice were treated with MC on day 17 of pregnancy and were increased sensitivity to chemically induced lung tumor formation as a result of in utero exposure to chemical carcinogens subsequently given BHT 6 weeks after birth to assess the modulation of MC-induced lung tumors by BHT. Molecular (2,3). BALB/c mice may not demonstrate this increased sensitivity following transplacental exposures. alterations in the proto-oncogene Ki-ras and the tumor suppressor genes p16 Ink4a and p19 ARF were determined. Briefly, Alterations in Ki-ras are frequently found in lung tumors of humans as well as experimental rodent models (16, 17, 38) . analyses of the genes were carried out with lysates from paraffin-embedded BALB/c lung tissue and compared with Each Ki-ras codon (12,13,61) was screened using ASO with six different mutant 20 bp oligonucleotide probes differing results obtained in previous studies on [D2ϫB6D2F 1 ]F 2 offspring treated by the same protocol. The lysates were subjected from the wild-type sequence by 1 bp. Twenty of the 36 lesions (56%) excised from BALB/c mice exhibited mutations in to DNA amplification followed by ASO screening and SSCP analysis. exon 1 or 2, a lower percentage than that observed in [D2ϫB6D2F 1 ]F 2 mice, where 37/47 lesions (79%) exhibited Gestational MC exposure at day 17 had no effect on maternal weight gain, length of pregnancy, birth weight, fetal mortality mutations in the first or second base of codons 12 or 13 (P ϭ 0.032). Figure 1 shows the results of the ASO analysis or post-natal weight gain (data not shown). BALB/c mice (CAA→CGA) mutation. Of the carcinomas, 27% (3/11) had example, 33% (2/6) of all the hyperplasias had a Cys12 transversion, while a wild-type Ki-ras sequence, 18% (2/11) exhibited a Cys12 67% (4/6) had the wild-type sequence. Note that one adenoma and one carcinoma contained two mutations.
(GGT→TGT) transversion, 9% (1/11) exhibited a Val12 (GGT→GTT) transversion, 46% (5/11) exhibited an Arg12 (GGT→CGT) mutation and 9% (1/11) exhibited an Arg13 of the Ki-ras gene in lung tumor tissue of BALB/c mice. As shown in the left panel, all of the PCR products from normal (GGC→CGC) transversion. None of the specific Ki-ras mutations differed significantly between tumor type. It should and tumor tissue hybridized to the wild-type Gly12 probe. The other five panels demonstrate hybridization with mutant probes.
be noted that one adenoma had both the Val12 and Arg13 mutations in the same tumor and that one carcinoma had both Two separate amplification reactions and ASO analyses were performed with each sample to ensure that the results were the Arg12 and Cys12 mutations in the same tumor. The presence of two different mutant Ki-ras alleles within the not due to Taq-induced errors during primary amplification. Randomly chosen PCR products were sequenced to confirm same tumor has been detected in other studies (37, 39) . Overall, the observed frequency of Ki-ras mutations in BALB/c lung the presence of these point mutations. All exon 1 Ki-ras mutations were at G residues; 38% of these were G→T tumors was 33% (2/6) in hyperplasias, 58% (10/19) in adenomas and 73% (8/11) in carcinomas. transversions and 62% were G→C transversions. This is in contrast to that observed in the [D2ϫB6D2F 1 ]F 2 mice, where
The inactivation of tumor suppressor genes, such as p16 Ink4a , has been shown to play an important role in tumorigenesis 84% of the Ki-ras mutations were G→T transversions and 13% were G→C transversions (37) . (40), SSCP and subsequent sequence Of the hyperplasias, 67% (4/6) had the wild-type Ki-ras sequence and 33% (2/6) exhibited a GGT→TGT (Gly12→ analyses showed the presence of two point mutations in exon 2 of p16 Ink4a in BALB/c mice (Figure 3 ). Tumor samples 7 Cys12) transversion (Figure 2) . Of the adenomas, 47% (9/19) had the wild-type sequence, 5% (1/19) exhibited a Cys12 and 19 both exhibited a GTA→ATA (Val51→Ile) transition. These G→A mutations were also found in lung (40) and liver (GGT→TGT) transversion, 11% (2/19) exhibited a Val12 (GGT→GTT) transversion, 16% (3/19) exhibited an Arg12 tumors of transplacentally MC-treated mice (41) and suggest the possibility that endogenous aberrant methylation may have (GGT→CGT) mutation, 21% (4/19) exhibited an Arg13 (GGC→CGC) transversion and 5% (1/19) exhibited an Arg61 mediated damage to the p16 Ink4a gene. The codon number is mutations and 82% (9/11) of late stage adenomas to exhibit the [D2ϫB6D2F 1 ]F 2 lesions exhibiting a preponderance of L81167), in which an additional GCC (Ala) triplet at codon G→T (84%) mutations. Whether the different mutant RAS 11 is present relative to the sequence reported by Quelle et al. proteins influence the oncogenic potential of the lung lesions (42) . No mutations were observed by SSCP analyses in exon is currently not known. 1α of the p16 Ink4a gene or exon 1β of the p19 ARF gene. Previous
The Cys12 mutations observed in the neoplasms of both studies by this and other laboratories (reviewed in ref. 43) strains were present predominantly in the earlier stage tumors have failed to identify mutations in p53 in rodent lung tumors, (hyperplasias), while the other mutations, Val12, Arg12, Arg13 hence, this gene was not screened in the present study.
and Arg61, were found only in the later stage neoplasms. Thus, Cys12 may have less oncogenic potential than the other Discussion early alterations. Similar findings have been found in adult mice. In a study by Nuzum et al. (49), urethane-induced Our laboratory has been studying the interaction between environmental and genetic factors in the induction of lung lung adenomas in A/J mice primarily exhibited a leucine transversion at codon 61 of Ki-ras, while lung adenocarcinomas tumors following in utero exposure to dietary and environmental carcinogens, as carcinogen susceptibility has been primarily exhibited an Arg transition at codon 61. These findings are important in that determining the types of mutations determined in the adult but not the developing organism. Utilizing 3-MC as a model carcinogen, we previously demonpresent in a tumor could provide prognostic data as to the potential of the tumor to progress to a more malignant strated that transplacentally treated [D2ϫB6D2F 1 ]F 2 mice develop lung and liver tumors. The present study sought to phenotype. This could ultimately have diagnostic, as well as prognostic, value. examine the carcinogenicity of transplacental exposure to MC in BALB/c mice and to compare these results with those
The percentage of BALB/c lung tumors with mutations in exon 2 of p16 Ink4a agreed well with the percentage found previously reported in the more resistant [D2ϫB6D2F 1 ]F 2 mouse strain (24) . In addition, we were interested in assessing previously in [D2ϫB6D2F 1 ]F 2 mice (40), 6 and 7%, respectively. This relatively low incidence of p16 Ink4a mutations is the molecular pathogenesis of the chemically induced tumors, as well as the modulatory effects of BHT in BALB/c lung consistent with that reported by Herzog et al. (50) in which frequent inactivation of p16 Ink4a was observed in mouse lung tumors.
In utero exposure to MC induced lung tumors in both the tumor cell lines (72%), while infrequent inactivation of p16 Ink4a was observed in primary mouse lung carcinomas (6%). All Whether or not endogenous methylation-mediated damage is related to CpG sites or transcriptional silencing of the mutations, 56 (20/36) and 79% (37/47), respectively. There was a predominance of guanine mutations which is consistent p16 Ink4a gene due to aberrant hypermethylation of the promoter region (54) remains a question. While the p16 Ink4a polymorwith the metabolism of MC to reactive electrophiles that bind mainly to guanine bases to form DNA adducts (44). Such phisms found in these different strains do not appear to be determinants of structural alterations in this gene, they may adduct profiles are found in both fetal and adult tissues (13). An increase in the incidence of mutations in Ki-ras was alter susceptibility of these mice to methylation. No mutations in exon 1β of p19 ARF were observed in lung tumor tissue observed in the progression of BALB/c and [D2ϫB6D2F 1 ]F 2 lung tumors from hyperplasias to adenomas to carcinomas excised from BALB/c or [D2ϫB6D2F 1 ]F 2 mice. p19 ARF , the alternative p16 Ink4a transcript, has been demonstrated to indir- (Table III) . More specifically, in BALB/c and [D2ϫB6D2F 1 ]F 2 mice 73-100% of the carcinomas exhibited Ki-ras mutations ectly decrease cell proliferation by binding to the MDM2 protein, preventing its inhibition of p53 (54-56). Despite its compared with 33-60% of the hyperplasias. This trend has also been observed in carcinogen-treated adult mice. As shown apparent importance in cell growth regulation, results from this and other studies (57) suggest that the p19 ARF gene may in Table III development later in adult life.
